Page 179 - Eceptor News Today

Deep mutational learning (DML) is a technique developed by researchers from multiple institutions that combines experimental yeast display screening of RBD mutagenesis libraries with deep sequencing and machine learning.

A group of researchers from various institutions developed a nucleoside-modified mRNA vaccine that encodes the SARS-CoV-2 N protein (mRNA-N) and is formulated in lipid nanoparticles for this investigation (LNP).

A new study discusses a computational program that can be used to substitute for actual experimental evidence of the biologic impact of new mutations.

A new study reports a method using four PCR tests to distinguish infection with the Omicron variant from that caused by other variants.

Researchers determined antibody-mediated neutralization efficacy against the authentic SARS-CoV-2 Omicron variant.

To combat the global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, vaccinations and treatment procedures have been developed at a breakneck pace.

A new study demonstrates lethal infection of the olfactory epithelium in a mouse model that could help understand the mechanisms of COVID-19.

At the 2021 American Society of Hematology (ASH) Annual Meeting Regulatory News: OSE Immunotherapeutics SA (Paris:OSE) (ISIN: FR0012127173; Mnemo: OSE) presented the first preclinical data on

Researchers from the Biological Defence Programme of Singapore have investigated six of these antibodies.

A review assessed the impact of "hot" vs. "cold" immune/tumor environments (and associated therapies) on susceptibility and disease course in subjects with these two types of tumors and infected with SARS-CoV-2 to decipher the mechanisms that drive these adverse outcomes in COVID-19 infected cancer patients.